Grundläggande statistik
| CIK | 806592 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Sunwin Stevia International, Inc.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| August 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 86803D109 (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended April 30, 2023 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transit |
|
| June 9, 2023 |
Russell Bedford Exhibit 16.1 805 Third Avenue Suite 1430 New York, New York 10022-7513 212.868.3669 212.838.2676/ Fax www.rbsmllp.com June 8, 2023 Securities and Exchange Commission 100 F Street, N.W. Washington, DC 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Sunwin Stevia International, Inc. (the “Company”) Form 8-K dated June 8, 2023, and are in agreement with the statements relating |
|
| June 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 8, 2023 Sunwin Stevia International, Inc. |
|
| March 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 86803D109 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended January 31, 2023 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| January 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN S |
|
| December 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 86803D109 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended October 31, 2022 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STE |
|
| September 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 86803D109 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended July 31, 2022 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transiti |
|
| August 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA INTERNATIO |
|
| August 10, 2022 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 2. Sunwin USA, LLC., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Delaware 3. Qufu Shengren Import and Export Co., Ltd. (?Qufu Shengren Import and Export? |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 86803D109 (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended April 30, 2022 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transit |
|
| April 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 86803D109 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended January 31, 2022 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| March 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 11, 2022 Sunwin Stevia International, Inc. |
|
| December 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 86803D109 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended October 31, 2021 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| October 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 30, 2021 Sunwin Stevia International, Inc. |
|
| September 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STE |
|
| September 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 7, 2021 Sunwin Stevia International, Inc. |
|
| July 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA INTERN |
|
| July 27, 2021 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 2. Sunwin USA, LLC., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Delaware 3. Qufu Shengren Import and Export Co., Ltd. (?Qufu Shengren Import and Export? |
|
| March 15, 2021 |
Quarterly Report - SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 suwn10-q.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the |
|
| September 11, 2020 |
Quarterly Report - SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| August 3, 2020 |
Annual Report - SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA INTERN |
|
| August 3, 2020 |
Subsidiaries of the registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 2. Sunwin USA, LLC., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Delaware 3. Qufu Shengwang Stevia Biology and Science Co., Ltd., a wholly owned subsidia |
|
| July 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): ⌧ Form 10-K □ Form 20-F □ Form 11-K □ Form 10-Q □ Form 10-D □ Form N-SAR □ Form N-CSR For Period Ended April 30, 2020 □ Transition Report on Form 10-K □ Transition Report on Form 20-F □ Transition Report on Form 11-K □ Transit |
|
| July 9, 2020 |
8-K 1 suwn8-k.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 6, 2020 Sunwin Stevia International, Inc. (Exact name of registrant as specified in its charter) Nevada 000-53595 56-241 |
|
| March 16, 2020 |
10-Q 1 suwn10-q.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the |
|
| December 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| September 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| August 13, 2019 |
Subsidiaries of the registrant. Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 2. Sunwin USA, LLC., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Delaware 3. Qufu Shengwang Stevia Biology and Science Co., Ltd., a wholly owned subsidia |
|
| August 13, 2019 |
10-K 1 suwn10-k.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition perio |
|
| August 5, 2019 |
Exhibit 10.31 Asset Transfer Agreement (Translation) Party A: Qufu Natural Green Engineering Co., Ltd. ("Qufu Natural Green", "Seller") Party B: Na Li ("Buyer") Through friendly negotiation, the Parties have agreed to enter into cooperation regarding Party A's transfer of asset, the Parties have agreed to the following: 1. Party A agrees to transfer its subsidiary "Qufu Shengwang Stevia Biology an |
|
| August 5, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2019 Sunwin Stevia International, Inc. |
|
| July 29, 2019 |
SUWN / Sunwin Stevia International, Inc. NT 10-K - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): ☒Form 10-K ☐Form 20-F ☐Form 11-K ☐Form 10-Q ☐Form 10-D ☐Form N-SAR ☐Form N-CSR For Period Ended April 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Rep |
|
| July 15, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 10, 2019 Sunwin Stevia International, Inc. |
|
| July 15, 2019 |
Exhibit 10.30 Metformin Production Line Operation Management Agreement (Translation from original Chinese Agreement is provided only for reference) Party A: Qufu Shengren Pharmaceutical Co., Ltd (the "Company") Party B: Ru Yuan In order to improve corporate management, increase economic efficiency, and improve the quality, model, branding of the metformin raw material accordance with the nation's |
|
| March 18, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 17, 2018 |
10-Q 1 suwn10-q.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the |
|
| September 14, 2018 |
SUWN / Sunwin Stevia International, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| July 30, 2018 |
Subsidiaries of the registrant.* Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 2. Qufu Chinese Medicine Factory , a wholly owned subsidiary of Qufu Natural Green Engineering Co., Ltd. China 3. Sunwin USA, LLC., a wholly owned subsidiary of Sunwin Stevia Int |
|
| July 30, 2018 |
SUWN / Sunwin Stevia International, Inc. SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2018 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA INTERN |
|
| March 16, 2018 |
10-Q 1 10-q.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2018 or [ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran |
|
| December 15, 2017 |
10-Q 1 suwn10-q.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the |
|
| September 14, 2017 |
SUWN / Sunwin Stevia International, Inc. SUNWIN STEVIA INTERNATIONAL, INC. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| July 31, 2017 |
SUWN / Sunwin Stevia International, Inc. SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA INTERN |
|
| July 31, 2017 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 3. Qufu Chinese Medicine Factory , a wholly owned subsidiary of Qufu Natu |
|
| March 17, 2017 |
Sunwin Stevia International SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q (Quarterly Report) suwn10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: |
|
| January 20, 2017 |
Sunwin Stevia International SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q (Quarterly Report) 10-Q 1 suwn10-q.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the |
|
| December 16, 2016 |
Sunwin Stevia International 0-Q suwnnt10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended October 31, 2016 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Fo |
|
| September 13, 2016 |
Sunwin Stevia International SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q (Quarterly Report) suwn10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000 |
|
| July 29, 2016 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 3. Qufu Chinese Medicine Factory , a wholly owned subsidiary of Qufu Natu |
|
| July 28, 2016 |
Sunwin Stevia International SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-K (Annual Report) 10-K 1 suwn10-k.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition perio |
|
| March 15, 2016 |
Sunwin Stevia International SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 16, 2015 |
Sunwin Stevia International 0-Q NT 10-Q 1 suwnnt10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended October 31, 2015 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Re |
|
| September 14, 2015 |
CONSULTING AGREEMENT FOR STOCK COMPENSATION Exhibit 10.30 CONSULTING AGREEMENT FOR STOCK COMPENSATION AGREEMENT, dated as of August 11, 2015, Sunwin Stevia International, Inc. (OTCQB: SUWN, the ?Company?) located at 6 Shengweng Avenue, Qufu, China 273100 and Yuejian Wang located at 17815 Cadena Drive, Boca Raton, FL 33496 (the ?Consultant?). WITNESSETH: WHEREAS, the Company has agreed to engage in the Consultant to provide the Company with |
|
| September 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| August 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [?] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA INTERN |
|
| August 6, 2015 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 3. Qufu Chinese Medicine Factory , a wholly owned subsidiary of Qufu Natu |
|
| August 6, 2015 |
CONSULTING AGREEMENT FOR STOCK COMPENSATION Exhibit 10.29 CONSULTING AGREEMENT FOR STOCK COMPENSATION AGREEMENT, dated as of May 5, 2015, Sunwin Stevia International, Inc. (OTCQB: SUWN, the ?Company?) located at 6 Shengweng Avenue, Qufu, China 273100 and Yuejian Wang located at 17815 Cadena Drive, Boca Raton, FL 33496 (the ?Consultant?). WITNESSETH: WHEREAS, the Company has agreed to engage the Consultant to provide the Company with consult |
|
| July 29, 2015 |
Sunwin Stevia International 0-K nt10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended April 30, 2015 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11- |
|
| May 18, 2015 |
Sunwin Stevia International SUNWIN STEVIA INTERNATIONAL, INC. FORM S-8 suwns-8.htm As filed with the Securities and Exchange Commission on May 18, 2015 Registration No: 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sunwin Stevia International, Inc. (Exact name of registrant as specified in its charter) Nevada 56-2416925 (State or other jurisdiction of incorporation or orga |
|
| May 12, 2015 |
Financial Statements and Exhibits, Other Events suwn8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 11, 2015 SUNWIN STEVIA INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-53595 56-2416925 (State or other jurisdiction of incorporatio |
|
| May 12, 2015 |
SUNWIN STEVIA INTERNATIONAL, INC. 2015 EQUITY COMPENSATION PLAN exh10-29.htm SUNWIN STEVIA INTERNATIONAL, INC. 2015 EQUITY COMPENSATION PLAN 1. Purpose. 1.1 Purpose. The purpose of the Sunwin Stevia International, Inc. 2015 Equity Compensation Plan is to enable the Company to offer to its employees, officers, directors and consultants whose past, present and/or potential contributions to the Company and its Subsidiaries have been, are or will be important to t |
|
| May 4, 2015 |
suwn8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 1, 2014 Sunwin Stevia International, Inc. (Exact name of registrant as specified in its charter) Nevada 000-53595 56-2416925 (State or other jurisdiction of incorpora |
|
| March 17, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 22, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 15, 2014 |
SUWN / Sunwin Stevia International, Inc. NT 10-Q - - SUNWIN STEVIA INTERNATIONAL, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended October 31, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| October 10, 2014 |
Exhibit 1 Exhibit 1 JOINT FILING AGREEMENT Archer-Daniels-Midland Company, a Delaware corporation, ADM Holdings LLC, a Delaware limited liability company, and Archer Daniels Midland Europe B. |
|
| October 10, 2014 |
Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Sunwin Stevia International, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 867877102 (CUSIP Number) D. Cameron Findlay Senior Vice President, General Counsel and Secretary Archer-Daniels-Midland Company 77 West W |
|
| September 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| July 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No. 1 (Mark One) [ü] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SU |
|
| July 29, 2014 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 3. Qufu Chinese Medicine Factory , a wholly owned subsidiary of Qufu Natu |
|
| July 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [?] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended April 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA INTERN |
|
| March 24, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| March 17, 2014 |
NT 10-Q 1 suwnnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended January 31, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Rep |
|
| December 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| December 9, 2013 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - SUNWIN8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 5, 2013 SUNWIN STEVIA INTERNATIONAL, INC. |
|
| December 9, 2013 |
RBSM LLP Certified Public Accountants 805 Third Avenue, Suite 902 New York, New York 10022 Exhibit 16.1 RBSM LLP Certified Public Accountants 805 Third Avenue, Suite 902 New York, New York 10022 December 6, 2013 Securities and Exchange Commission 100 F Street, N.W. Washington, DC 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Sunwin Stevia International, Inc. (the “Company”) Form 8-K dated December 5, 2013, and are in agreement with the statements relating only to RBSM LLP conta |
|
| September 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2013 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| August 2, 2013 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 3. Qufu Chinese Medicine Factory , a wholly owned subsidiary of Qufu Natu |
|
| August 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [?] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year report ended April 30, 2013 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN STEVIA |
|
| July 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended April 30, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transit |
|
| March 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended January 31, 2013 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| March 18, 2013 |
- SUNWIN STEVIA INTERNATIONAL, INC. FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended January 31, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| February 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2013 Sunwin Stevia International, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-53595 (Commission |
|
| February 25, 2013 |
EXHIBIT 16.1 February 22, 2013 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 We have read Item 4.01 included in the Form 8-K of Sunwin Stevia International, Inc. dated February 21, 2013, to be filed with the Securities and Exchange Commission. We agree with the statements concerning our Firm in such Form 8-K. We have no basis to agree to disagree with other stat |
|
| December 17, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 suwn8-k.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 17, 2012 Sunwin Stevia International, Inc. (Exact name of registrant as specified in its charter) Nevada 000-53595 5 |
|
| December 17, 2012 |
Exhibit 99.1 Sunwin Stevia International Sees Resumption of Sales Growth in the Coming Fiscal Year The Company Expects Sales to reach $18 million in Fiscal 2014 with $2 million in Net Operating Income QUFU, CHINA – December 17, 2012 - Sunwin Stevia International, Inc., “Sunwin Stevia” (OTC QB: SUWN), one of the top global providers of high quality stevia extracts including Rebaudioside A 98, annou |
|
| December 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended October 31, 2012 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 14, 2012 |
Exhibit 10.33 CONSULTING AGREEMENT This CONSULTING AGREEMENT, dated as of September 14, 2012 between Sunwin Stevia International, Inc., a Nevada corporation (the ?Company?), and Dore Perler (the ?Consultant?). WITNESSETH: WHEREAS, the Company has agreed to engage the Consultantto provide the Company with sales consulting and managerial services related to the Company?s operations in North America. |
|
| September 12, 2012 |
Fiscal Year 2013 Consulting Agreement Exhibit 10.32 Fiscal Year 2013 Consulting Agreement (Translation) Party A: Sunwin Stevia International, Inc. Party B: China Direct Investments, Inc. After friendly consultations between both parties, Party A hereby agrees to engage Party B to provide consulting services in fiscal year 2013 pursuant to the terms and conditions defined as follows. I. This agreement shall be executed during Party A?s |
|
| September 12, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended July 31, 2012 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| August 30, 2012 |
Exhibit 4 JOINT FILING AGREEMENT Dr. Hans-Peter Wild, WILD Flavors, Inc., a Delaware corporation, WILD Affiliated Holdings, Inc., a Nevada corporation, and WILD Flavors GmbH, a Swiss corporation, each hereby agree, in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, that the Schedule 13D filed herewith, and any amendments thereto, relating to the shares of common stock of S |
|
| August 30, 2012 |
SUWN / Sunwin Stevia International, Inc. / WILD Flavors, Inc. - SC 13D Activist Investment CUSIP No. 867877102 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Sunwin Stevia International, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 867877102 (CUSIP Number) WILD Flavors, Inc. c/o Louis |
|
| August 28, 2012 |
Sunwin Stevia International and WILD Flavors GmbH Enter Into Worldwide Stevia Distribution Agreement Exhibit 99.1 Sunwin Stevia International and WILD Flavors GmbH Enter Into Worldwide Stevia Distribution Agreement WILD Flavors GmbH acquires additional 7.67 million shares of Sunwin Stevia International in exchange for its stake in Sunwin USA and grants the exclusive ownership to certain stevia formulations QUFU, CHINA – August 27, 2012 - Sunwin Stevia International, Inc. “Sunwin” (OTC.BB:SUWN) on |
|
| August 28, 2012 |
S-8 1 suwns-8.htm FORM S-8 As filed with the Securities and Exchange Commission on August 28, 2012 Registration No: 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sunwin Stevia International, Inc. (Exact name of registrant as specified in its charter) Nevada 56-2416925 (State or other jurisdiction of inc |
|
| August 28, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 28, 2012 Sunwin Stevia International, Inc. |
|
| August 24, 2012 |
AMENDMENT TO OPERATING AGREEMENT Exhibit 10.30 AMENDMENT TO OPERATING AGREEMENT THIS AMENDMENT TO OPERATING AGREEMENT (the “Amendment”) is made effective as of August 8, 2012 by and between WILD FLAVORS, INC., a Delaware corporation (“WILD Flavors”) and Sunwin Stevia International, Inc., a Nevada corporation (“Sunwin”). WILD Flavors and Sunwin may collectively be referred to as the “Parties”. BACKGROUND A. WILD Flavors and Sunwin |
|
| August 24, 2012 |
Exhibit 10.29 EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (the “Agreement”) is made as of August 8, 2012 between WILD FLAVORS, INC., a Delaware corporation (“Seller”), and Sunwin Stevia International, Inc., a Nevada corporation (“Purchaser”). Seller and Purchaser as hereinafter collectively referred to as the “Parties”. Sunwin USA, LLC, a Delaware limited liability company (“Sunwin USA”) joins in t |
|
| August 24, 2012 |
SUNWIN STEVIA INTERNATIONAL, INC. 2012 EQUITY COMPENSATION PLAN Exhibit 4.4 SUNWIN STEVIA INTERNATIONAL, INC. 2012 EQUITY COMPENSATION PLAN 1. Purpose. 1.1 Purpose. The purpose of the Sunwin Stevia International, Inc. 2012 Equity Compensation Plan is to enable the Company to offer to its employees, officers, directors and consultants whose past, present and/or potential contributions to the Company and its Subsidiaries have been, are or will be important to th |
|
| August 24, 2012 |
8-K 1 suwn8-k.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 8, 2012 SUNWIN STEVIA INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Nevada 000-53595 56-2 |
|
| August 24, 2012 |
TERMINATION OF DISTRIBUTION AGREEMENT Exhibit 10.31 TERMINATION OF DISTRIBUTION AGREEMENT THIS TERMINATION OF DISTRIBUTION AGREEMENT (the “Termination Agreement”) is made effective as of August 8th, 2012 by and between WILD FLAVORS, INC., a Delaware corporation (“WILD Flavors”), Sunwin Stevia International, Inc., a Nevada corporation (“Sunwin International”) and Sunwin USA, LLC, a Delaware limited liability company (“Sunwin USA”). WIL |
|
| August 24, 2012 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 24, 2012 SUNWIN STEVIA INTERNATIONAL, INC. |
|
| July 30, 2012 |
EXHIBIT 10.28 Cooperation Agreement (Translation) Party A: Hegeng (Beijing) Organic Farm Technology Co, Ltd. (hereafter “Party A”) Party B: Qufu Shengwang Stevia Biology and Science Co., Ltd. (hereafter “Party B”) Pursuant to the Contract Law of the People’s Republic of China and other applicable laws and regulations, Party A and Party B have negotiated under the principles of equality and mutual |
|
| July 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 10-K 1 suwn10-k.htm SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K [ü ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2012 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PER |
|
| July 30, 2012 |
Sunwin Stevia International, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin Stevia International, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin Stevia International, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin Stevia International, Inc. China 3. Qufu Chinese Medicine Factory , a wholly owned subsidiary of Qufu Natu |
|
| May 14, 2012 |
SUWN / Sunwin Stevia International, Inc. / WILD Flavors, Inc. - SC 13G Passive Investment UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0145 SCHEDULE 13G Expires: November 30, 2012 Under the Securities Exchange Act of 1934 Estimated average burden hours per response. . 10 Sunwin International Neutraceuticals, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 867877102 (CUSIP Number) Dece |
|
| May 14, 2012 |
Exhibit 99.1 JOINT FILING AGREEMENT Dr. Hans-Peter Wild, WILD Flavors, Inc., a Delaware corporation, WILD Affiliated Holdings, Inc., a Nevada corporation, and WILD Flavors GmbH, a Swiss corporation, each hereby agree, in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, that the Schedule 13G filed herewith, and any amendments thereto, relating to the shares of common stock o |
|
| April 20, 2012 |
EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER by and between SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. a Nevada corporation and SUNWIN STEVIA INTERNATIONAL, INC. a Nevada corporation AGREEMENT AND PLAN OF MERGER, dated as of March 28, 2011, between Sunwin Stevia International, Inc., a Nevada corporation (the “Subsidiary”), and Sunwin International Neutraceuticals, Inc., a Nevada corporation (the “Pare |
|
| April 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 20, 2012 SUNWIN STEVIA INTERNATIONAL, INC. |
|
| April 20, 2012 |
EXHIBIT 3.3 |
|
| April 20, 2012 |
EX-99.1 4 exh99-1.htm PRESS RELEASE DATED APRIL 20, 2012. EXHIBIT 99.1 Sunwin International Neutraceuticals Changes Corporate Name to Sunwin Stevia International Qufu, China-(4/20/12) – Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) one of the top global providers of high quality stevia extracts including Rebaudioside A 98, announced today that the company has changed its name to Sunwin |
|
| March 19, 2012 |
EX-10.25 3 exh10-25.htm SUPPLIER AGREEMENT DATED DECEMBER 2, 2012 BY AND BETWEEN SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND DOMINO FOODS, INC. Exhibit 10.25 SUPPLIER AGREEMENT THIS SUPPLIER AGREEMENT (the “Agreement”) is made by and between Domino Foods, Inc., as agent for its Affiliates, American Sugar Refining, Inc., Redpath Sugars Ltd. Okeelanta Corporation, T&L Sugars Limited, Domino Comer |
|
| March 19, 2012 |
Exhibit 10.26 Loan Agreement (Translation) Party A：Qufu Natural Green Engineering Co., Ltd. Party B：Shandong Anda Bio-Tech Co., Ltd. WHEREAS, Party B applied for a loan from Party A and both parties negotiated the terms in good faith; NOW, therefore, both parties have agreed to enter this loan agreement under the terms and conditions as follows: 1. Party A will loan RMB 20,000,000 (twenty million) |
|
| March 19, 2012 |
Exhibit 10.24 Loan Agreement (Translation) Party A?Qufu Natural Green Engineering Co., Ltd. Party B?Shandong Shengwang Pharmaceutical Co., Ltd. WHEREAS, Party B applied for a loan from Party A and both parties negotiated the terms in good faith; NOW, therefore, both parties have agreed to enter this loan agreement under the terms and conditions as follows: 1. Party A will loan RMB 20,000,000 (twen |
|
| March 19, 2012 |
Confirmation of the Amendment to Loan Agreement Exhibit 10.27 Confirmation of the Amendment to Loan Agreement This is to confirm the amendment to the due date of the Loan Agreement that was entered by both parties on November 18, 2011. It is amended as such that Shandong Shengwang Pharmaceutical Co., Ltd. shall pay back the full amount of principal by April 20, 2012. Shandong Shengwang Pharmaceutical Co., Ltd. Signature: /s/Laiwang Zhang March |
|
| March 19, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended January 31, 2012 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| March 19, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended January 31, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| February 24, 2012 |
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. 6 Shengwang Avenue Qufu, Shandong, China February 24, 2012 'CORRESP' United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Gus Rodriguez, Accounting Branch Chief Kei Nakada, Staff Accountant Mike Rosenthall, Staff Attorney Jennifer Riegel, Special Counsel R |
|
| December 15, 2011 |
EX-10.22 2 exh10-22.htm STOCK TRANSFER AGREEMENT BETWEEN KOREA STEVIA CO, LTD. AND QUFU SHENGWANG STEVIA BIOLOGY AND SCIENCE CO., LTD. DATED SEPTEMBER 30, 2011. Exhibit 10.22 Stock Transfer Agreement (Translation) Party A: Korea Stevia Co, Ltd. Authorized Representative: Jeong Ill-hwan, Kim Ee Youp Address: Jeopji-ri, Ibam-myeon Jeongeup-si Jeollabuk-do 538-12 Korea Party B: Qufu Shengwang Stevia |
|
| December 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended October 31, 2011 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 15, 2011 |
COMMERCIAL HOUSING PURCHASE AND SALE CONTRACT Signing Date: August 25, 2011 EX-10.23 3 exh10-23.htm COMMERCIAL HOUSING PURCHASE AND SALE CONTRACT BETWEEN QUFU JINXUAN REAL ESTATE DEVELOPMENT CO., LTD. AND QUFU NATURAL GREEN ENGINEERING CO., LTD. DATED AUGUST 25, 2011. Exhibit 10.23 COMMERCIAL HOUSING PURCHASE AND SALE CONTRACT (Translation) Signing Date: August 25, 2011 - 1 - Notes on Commercial Housing Purchase and Sale Contract 1. This contract is used for signing purpo |
|
| September 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended July 31, 2011 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| September 14, 2011 |
Listing Company Consulting Services Agreement for Fiscal 2012 EX-10.21 2 exh10-21.htm CONSULTING AGREEMENT BETWEEN CHINA DIRECT INVESTMENTS, INC. AND SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC DATED APRIL 22, 2011. Exhibit 10.21 Listing Company Consulting Services Agreement for Fiscal 2012 Party A: Sunwin International Neutraceuticals, Inc. Party B: China Direct Investments, Inc. Both parties reached an agreement to have Party B provide listing company consul |
|
| July 29, 2011 |
Sunwin International Neutraceuticals, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin International Neutraceuticals, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. China 3. Qufu Chinese Medicine Factory , a wholly ow |
|
| July 29, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K [ü ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2011 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-53595 SUNWIN INTERNATION |
|
| July 14, 2011 |
Sunwin International Neutraceuticals to Present at the 2011 Global Hunter Securities Conference EX-99.1 2 exh99-1.htm PRESS RELEASE OF SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC., DATED JULY 13, 2011 Exhibit 99.1 Sunwin International Neutraceuticals to Present at the 2011 Global Hunter Securities Conference QUFU, CHINA - July 13, 2011 - Sunwin International Neutraceuticals, Inc. (OTC.BB:SUWN - News), one of the top global providers of high quality stevia extracts including Rebaudioside A 98, |
|
| July 14, 2011 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 13, 2011 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. |
|
| May 17, 2011 |
EX-99.1 2 suwnexh99-1.htm JOINT PRESS RELEASE OF SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC., DOMINO FOODS, INC. AND WILD FLAVORS GMBH DATED MAY 17, 2011 Exhibit 99.1 FOR IMMEDIATE RELEASE Sunwin International, WILD Flavors and Domino Sugar Collaborate to Leverage All Natural Sweetener Expertise Domino Sugar and WILD Utilizing Sunwin Stevia™ will Offer the Broadest Sweetening Options For Taste, Pri |
|
| May 17, 2011 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 17, 2011 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. |
|
| March 29, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 29, 2011 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. |
|
| March 29, 2011 |
Exhibit 99.1 Sunwin Receives ISO 22000, ISO 9001:2008 and HACCP Integrated Systems Certifications These certifications represent an important step forward while introducing its Sunwin Stevia? Extracts to the North American and European food and beverage industry Qufu, China, March 29, 2011 ? Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), one of the top global providers of high quality s |
|
| March 17, 2011 |
[Translated from Chinese to English] Exhibit 10.23 [Translated from Chinese to English] Loan Agreement Party A: CDI China, Inc. Party B: Sunwin Tech Group, Inc. After negotiation and consultation between Party A and Party B, in regards to the matter of Party B providing a loan to Party A, the parties have established the below Loan Agreement dated December 20, 2010: Clause 1: Amount The amount of the loan for this Loan Agreement shal |
|
| March 17, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended January 31, 2011 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended October 31, 2010 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| September 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended July 31, 2010 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| July 29, 2010 |
Memorandum on Consulting Services for SUWN in Fiscal 2011 (Translation from Chinese to English) EX-10.22 2 exh10-22.htm MEMORANDUM ON CONSULTING SERVICES DATED MARCH 31, 2010 BETWEEN SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND CHINA DIRECT INVESTMENTS, INC. Exhibit 10.22 Memorandum on Consulting Services for SUWN in Fiscal 2011 (Translation from Chinese to English) Party A: Sunwin International Neutraceuticals, Inc. Party B: China Direct Investments, Inc. After friendly consultations betw |
|
| July 29, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2010 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-53595 SUNWIN INTERNATIONAL NE |
|
| July 6, 2010 |
Sunwin Sells Veterinary Medicine Subsidiary to Focus on Core Stevia and Herb Operations Exhibit 99.1 Sunwin Sells Veterinary Medicine Subsidiary to Focus on Core Stevia and Herb Operations QUFU, CHINA - 07/07/10 - Sunwin International Neutraceuticals, Inc. (OTC.BB:SUWN), one of the top global providers of high quality stevia extracts including Rebaudioside A 98, today announced that the Company has entered into a Stock Sale and Purchase Agreement to sell its 100% ownership interest i |
|
| July 6, 2010 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 29, 2010 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION |
|
| July 6, 2010 |
STOCK SALE AND PURCHASE AGREEMENT Exhibit 10.1 STOCK SALE AND PURCHASE AGREEMENT This STOCK SALE AND PURCHASE AGREEMENT (the "Agreement") dated as of June 29, 2010 is entered into by and between Qufu Natural Green Engineering Co., Ltd., a Chinese limited liability company (?Seller?) and a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. (the ?Company?), Shengya Veterinary Medicine Co., Ltd., a limited liabilit |
|
| June 30, 2010 |
SCHNEIDER WEINBERGER & BEILLY LLP SCHNEIDER WEINBERGER & BEILLY LLP 2200 Corporate Boulevard, N.W. Suite 210 Boca Raton, Florida 33431 telephone (561) 362-9595 telecopier (561) 362-9612 [email protected] June 30, 2010 'CORRESP' Mail Stop 4720 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Mark Brunhofer, Senior Staff Accountant |
|
| May 6, 2010 |
Sunwin International Neutraceuticals, Inc. 6 Shenwang Ave. Qufu, Shandong, China telephone (china) (86) 537-4424999 telecopier (954) 363-7320 [email protected] May 6, 2010 'CORRESP' Mail Stop 4720 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Mark Brunhofer, Senior Staff Accountant Kei Nakada, |
|
| March 25, 2010 |
EX-99.1 2 suwnex99-1.htm SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. MARCH 25, 2010 PRESS RELEASE Exhibit 99.1 Sunwin International and WILD Flavors, Inc. Receive GRAS Letters of No Objection from FDA Supporting the Safety of Multiple Sunwin Stevia Extracts Sunwin and WILD Flavors Offer the Broadest FDA GRAS Affirmed Stevia Options for Taste, Price and Flavor Needs QUFU, CHINA and ERLANGER, KY, Mar |
|
| March 25, 2010 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 23, 2010 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATIO |
|
| March 22, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2010 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| March 18, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-53595 NOTIFICATION OF LATE FILING CUSIP NUMBER 867877102 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended January 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| March 5, 2010 |
SCHNEIDER WEINBERGER & BEILLY LLP SCHNEIDER WEINBERGER & BEILLY LLP 2200 Corporate Boulevard, N.W. Suite 210 Boca Raton, Florida 33431 telephone (561) 362-9595 telecopier (561) 362-9612 [email protected] March 4, 2010 'CORRESP' Mail Stop 4720 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Mark Brunhofer, Senior Staff Accountant |
|
| December 16, 2009 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-142419 PROSPECTUS SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. 6,923,780 shares of Common Stock This prospectus relates to periodic offers and sales of 6,923,780 shares of our common stock by the selling security holders which represents shares of our common stock which are issuable upon the exercise of common stock purchase warrants with an exer |
|
| December 16, 2009 |
Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 16, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZA |
|
| December 16, 2009 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Sunwin International Reports Second Quarter 2010 Results Continued Development of Stevia Market Opportunity and High-Grade Supply Capability Qufu, China, December 15, 2009 – Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), today reported results for the fiscal 2010 second quarter ended October 31, 2009. Total revenue was $3.7 million compared to $3.4 mil |
|
| December 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended October 31, 2009 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUN |
|
| December 2, 2009 |
As filed with the Securities and Exchange Commission on December 2, 2009 Registration No. |
|
| December 2, 2009 |
Sunwin International Neutraceuticals, Inc. Subsidiaries of the Registrant Exhibit 21.1 Sunwin International Neutraceuticals, Inc. Subsidiaries of the Registrant Name Country of Incorporation Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. USA - Florida Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. China Shengya Veterinary Medicine Co., Ltd., a wholly owne |
|
| October 8, 2009 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 8, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATI |
|
| October 8, 2009 |
Sunwin International Neutraceuticals Signs Exclusive Distribution Agreement with Hunan Fuhui Flavors Exhibit 99.1 FOR IMMEDIATE RELEASE Sunwin International Neutraceuticals Signs Exclusive Distribution Agreement with Hunan Fuhui Flavors Qufu, China, October 8, 2009 ? Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), one of the world's leading producers of all-natural, zero-calorie stevia in China and a leader in the production and distribution of Chinese herbs and veterinary medicines ann |
|
| September 15, 2009 |
EX-99.1 2 exh99-1.htm SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. PRESS RELEASE DATED SEPTEMBER 15, 2009 Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Jeff Reynolds Sunwin USA, LLC. President & CEO 972.377.2339 [email protected] Contact: Kevin Gavin WILD Flavors, Inc. Chief Operating Officer 859.342.3534 [email protected] Sunwin International and WILD Flavors, Inc. Announce Self-GRAS (Gene |
|
| September 15, 2009 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 15, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZ |
|
| September 14, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended July 31, 2009 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53595 SUNWIN |
|
| September 10, 2009 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 10, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZ |
|
| September 10, 2009 |
Exhibit 99.1 |
|
| July 30, 2009 |
Results of Operations and Financial Condition, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): July 30, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION |
|
| July 30, 2009 |
Sunwin International Reports Financial Results for the Fiscal Year of 2009 EX-99.1 2 suwn8kex99-1.htm PRESS RELEASE OF SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. DATED JULY 30, 2009 Exhibit 99.1 Sunwin International Reports Financial Results for the Fiscal Year of 2009 · Record Sales of Stevioside reaching $14.5 Million, up from $12.9 Million in Fiscal 2008 · Revenue of $22 Million with Net Income of $500,000; · Total Cash of $10.49 Million, up 54% From Fiscal 2008; · To |
|
| July 29, 2009 |
Sunwin International Neutraceuticals, Inc. Subsidiaries of the Registrant EX-21.1 3 suwnex21-1.htm SUBSIDIARIES OF THE REGISTRANT. Exhibit 21.1 Sunwin International Neutraceuticals, Inc. Subsidiaries of the Registrant Name Country of Incorporation 1. Sunwin Tech Group, Inc., a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. USA - Florida 2. Qufu Natural Green Engineering Co., Ltd., a wholly owned subsidiary of Sunwin International Neutraceuticals, |
|
| July 29, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2009 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 033-10456 SUNWIN INTERNATIONAL NE |
|
| July 29, 2009 |
CONSULTING AND MANAGEMENT AGREEMENT EX-10.24 2 suwnex10-24.htm CONSULTING AND MANAGEMENT AGREEMENT BETWEEN SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND CHINA DIRECT INVESTMENTS, INC. DATED AS OF APRIL 29, 2009 Exhibit 10.24 CONSULTING AND MANAGEMENT AGREEMENT This Consulting and Management Agreement (“Agreement”) is made as of this 29th day of April, 2009 by and between Sunwin International Neutraceuticals, Inc., a Nevada corporat |
|
| April 8, 2009 |
Sunwin International Neutraceuticals Acquires 100% interest of Qufu Shengren Pharmaceutical Co., Ltd EX-99.1 2 suwnexhibit99-1.htm SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. PRESS RELEASE DATED APRIL 8, 2009 Exhibit 99.1 Sunwin International Neutraceuticals Acquires 100% interest of Qufu Shengren Pharmaceutical Co., Ltd · Acquisition Enables Sunwin to Increase High Grade Stevia Production Capacity to 250 tons Annually as It Positions to Meet Increasing Global Stevia Demand QUFU, CHINA-(MARKET WIR |
|
| April 8, 2009 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): April 8, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION |
|
| March 31, 2009 |
STOCK SALE AND PURCHASE AGREEMENT THIS STOCK SALE AND PURCHASE AGREEMENT (the "Agreement") is made and entered as of 25th day of March 2009 by and among Sunwin International Neutraceuticals, Inc. |
|
| March 31, 2009 |
ACQUISITION AGREEMENT THIS ACQUISITION AGREEMENT (the "Agreement") is made and entered as of March 25, 2009, by and among Qufu Natural Green Engineering Co. |
|
| March 31, 2009 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 25, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-53595 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATIO |
|
| March 16, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended January 31, 2009 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the transition period from to Commission file number: 033-10456 SUNW |
|
| March 9, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (Exact name of registrant has specified in its charter) Nevada 56-2146925 (State of incorporation or organization) (I.R.S. Employer Identification No.) 6 |
|
| February 25, 2009 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 20, 2009 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. |
|
| February 24, 2009 |
Filed pursuant to 424(b)(3) File No. 333-142419 PROSPECTUS SUPPLEMENT NO. 1 To Prospectus dated January 26, 2009 Sunwin International Neutraceuticals, Inc. 10,196,590 shares of Common Stock Our prospectus which forms a part of our Post-Effective Amendment No. 1 on Form S-1 to our Registration Statement on Form SB-2 as declared effective by the Securities and Exchange Commission on January 26, 2009 |
|
| February 11, 2009 |
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT EX-4.1 2 suwnex4-1.htm COMMON STOCK PURCHASE WARRANT BETWEEN SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND WILD FLAVORS, INC. DATED FEBRUARY 5, 2009. Exhibit 4.1 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE OR OTHER SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXER |
|
| February 11, 2009 |
EX-10.3 6 suwnex10-3.htm DISTRIBUTORSHIP AGREEMENT DATED FEBRUARY 5, 2009 AMONG SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC., SUNWIN STEVIA INTERNATIONAL CORP. AND WILD FLAVORS, INC. Exhibit 10.3 Portions of this Exhibit 10.3 marked by a [] have been omitted pursuant to a request for confidential treatment filed separately with the Commission. DISTRIBUTORSHIP AGREEMENT This DISTRIBUTORSHIP AGREEMENT |
|
| February 11, 2009 |
EX-99.1 7 suwnex99-1.htm PRESS RELEASE DATED FEBRUARY 11, 2008 Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Kevin Gavin WILD Flavors, Inc. Chief Operating Officer 859.342.3534 [email protected] Contact: Jeff Reynolds Sunwin USA President & CEO 972.377.2339 [email protected] WILD Flavors, Inc. Partners with Sunwin International Neutraceuticals, Inc. to Provide Zero-Calorie Stevia Extracts |
|
| February 11, 2009 |
EX-4.2 3 suwnex4-2.htm STOCKHOLDERS AGREEMENT DATED FEBRUARY 5, 2009 AMONG SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC., LAIWANG ZHANG, DONGDONG LIN, XINGYUAN LI, JUNZHEN ZHANG, XIANGSHENG KONG, WEIDONG CHAI, LAIWANG ZHANG, FANJUN WU AND WILD FLAVORS, INC. Exhibit 4.2 STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”) is entered into and effective as of February 5, 2009, by and am |
|
| February 11, 2009 |
OPERATING AGREEMENT SUNWIN USA LLC EX-10.2 5 suwnex10-2.htm FORM OF OPERATING AGREEMENT BETWEEN SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND WILD FLAVORS, INC. Exhibit 10.2 OPERATING AGREEMENT FOR SUNWIN USA LLC Units in Sunwin USA LLC (the “Company”) have not been registered with the Securities and Exchange Commission under the Securities Act of 1933, as amended, or the state securities laws of any state. Without such registrati |
|
| February 11, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 17, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATI |
|
| February 11, 2009 |
EX-10.1 4 suwnex10-1.htm SECURITIES PURCHASE AGREEMENT BETWEEN SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND WILD FLAVORS, INC. DATED FEBRUARY 5, 2009. Exhibit 10.1 SECURITIES PURCHASE AGREEMENT Dated as of February 5, 2009 By and Between Sunwin International Neutraceuticals, Inc. and Wild Flavors, Inc. SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is made an |
|
| January 14, 2009 |
As filed with the Securities and Exchange Commission on January 14, 2009 Registration No. |
|
| January 14, 2009 |
Subsidiaries of the registrant Exhibit 21.1 Subsidiaries of the Registrant Sunwin Tech Group, Inc., a Florida corporation. Qufu Natural Green Engineering Co., Ltd., a Chinese limited liability company. Sunwin Stevia International Corp., a Florida corporation. Sunwin (Canada) Pharmaceutical Ltd., a Canadian corporation. The following companies are subsidiaries of Qufu Natural Green Engineering Co. Ltd.: – Shengya Veterinary Medi |
|
| December 17, 2008 |
CONTACT: Company: Investors: Jeff Reynolds Matt Kreps 972-377-2339 469-362-5960 jreynolds@onlysweet. |
|
| December 17, 2008 |
Results of Operations and Financial Condition, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 17, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZA |
|
| December 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended October 31, 2008 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the transition period from to Commission file number: 033-10456 SUNW |
|
| November 26, 2008 |
Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(D) OF The Securities Exchange Act of 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 8, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORA |
|
| November 26, 2008 |
EX-10.19 2 ex10-19.htm NOVEMBER 18, 2008 SECOND AMENDMENT TO ACQUISITION AGREEMENT SECOND AMENDMENT TO ACQUISITION AGREEMENT THIS SECOND AMENDMENT (the “Second Amendment”) is made effective as of November 18, 2008 by and between QuFu Natural Green Engineering Co., Ltd., a limited liability company organized under the laws of the Peoples Republic of China (“Qufu Natural Green”), and Qufu Shengwang |
|
| November 26, 2008 |
SECOND AMENDMENT TO STOCK SALE AGREEMENT THIS SECOND AMENDMENT (the “Second Amendment”) is made effective as of November 18, 2008 by and between Sunwin International Neutraceuticals, Inc. |
|
| October 21, 2008 |
Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 21, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZAT |
|
| October 21, 2008 |
A vertically integrated global leader in the manufacturing of all natural stevia Exhibit 99.1 A vertically integrated global leader in the manufacturing of all natural stevia products, natural veterinary products and essential traditional Chinese medicines October 2008 www.sunwininternational.com www.onlysweet.com Legal Statement In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc., is |
|
| October 7, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No. |
|
| October 7, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K/A Amendment No. 4 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2008 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 033-10456 SUNWI |
|
| October 7, 2008 |
SCHNEIDER WEINBERGER & BEILLY LLP 2200 Corporate Boulevard, N.W. Suite 210 Boca Raton, Florida 33431 SCHNEIDER WEINBERGER & BEILLY LLP 2200 Corporate Boulevard, N.W. Suite 210 Boca Raton, Florida 33431 telephone (561) 362-9595 telecopier (561) 362-9612 [email protected] October 7, 2008 ‘CORRESP’ United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C 20549 Re: Sunwin International Neutraceuticals, Inc. (the “Company”) Item 4.02 Form 8-K Filed September 23, 2008 File No. 0 |
|
| September 23, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K/A (AMENDMENT NO. 3) [√] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED APRIL 30, 2008 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 033-10456 |
|
| September 23, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No. |
|
| September 23, 2008 |
SCHNEIDER WEINBERGER & BEILLY LLP 2200 Corporate Boulevard, N.W. Suite 210 Boca Raton, Florida 33431 SCHNEIDER WEINBERGER & BEILLY LLP 2200 Corporate Boulevard, N.W. Suite 210 Boca Raton, Florida 33431 telephone (561) 362-9595 telecopier (561) 362-9612 [email protected] September 22, 2008 ‘CORRESP’ United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C 20549 Re: Sunwin International Neutraceuticals, Inc. (the “Company”) Item 4.02 Form 8-K Filed September 12, 2008 File No |
|
| September 19, 2008 |
Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 19, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZ |
|
| September 19, 2008 |
EX-99 2 ex991.htm PRESS RELEASE DATED 09-19-2008 Exhibit 99.1 CONTACT: Company: Investors: Sunwin USA Magnolia Investor Relations Jeff Reynolds Matt Kreps 972-377-2339 469 362 5960 [email protected] [email protected] FOR IMMEDIATE RELEASE Sunwin International Neutraceuticals Reports Revenue, Cash Increases for Profitable 2009 First Quarter Q1 2009 revenue increases 48% to $6.2 million; Cas |
|
| September 17, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K/A Amendment No. 2 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2008 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 033-10456 SUNWI |
|
| September 16, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 033-10456 FORM 12b-25 CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one): Form 10-K Form 20-F Form 11-K X Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: July 31, 2008 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transi |
|
| September 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K/A x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2008 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 033-10456 SUNWIN INTERNATIONAL |
|
| September 12, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 11, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. |
|
| September 8, 2008 |
AMENDMENT TO ACQUISITION AGREEMENT Exhibit 10.15 AMENDMENT TO ACQUISITION AGREEMENT THIS AMENDMENT (the “Amendment”) is made effective as of September 2, 2008 by and between QuFu Natural Green Engineering Co., Ltd., a limited liability company organized under the laws of the Peoples Republic of China (“Qufu Natural Green”), and Qufu Shengwang Stevia Biology and Science Co., Ltd., a limited liability company organized under the laws |
|
| September 8, 2008 |
AMENDMENT TO STOCK SALE AGREEMENT Exhibit 10.16 AMENDMENT TO STOCK SALE AGREEMENT THIS AMENDMENT (the “Amendment”) is made effective as of September 2, 2008 by and between Sunwin International Neutraceuticals, Inc., a Nevada corporation, (“Sunwin International”) and Shandong Shengwang Group Co., Ltd. a limited liability company organized under the laws of the Peoples Republic of China (“Shandong Shengwang”). Sunwin International a |
|
| September 8, 2008 |
Exhibit 99.1 Sunwin International Neutraceuticals Acquires 60% interest in Qufu Shengwang Stevia Biology and Science Company The Company Enters Business of Organic Bio-Fertilizer and Organic Animal Feed QUFU, CHINA-(MARKET WIRE)—September 8, 2008 – Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one o |
|
| September 8, 2008 |
8-K 1 sunwin8-k.htm 8-K FOR 09-02-2008 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): September 2, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JU |
|
| July 29, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (MARK ONE) FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2008 OR o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 033-10456 SUNWIN INTERNATIONAL NE |
|
| July 7, 2008 |
Exhibit 10.13 AGREEMENT THIS ACQUISITION AGREEMENT (the “Agreement”) is made and entered as of June 30, 2008, by and among QuFu Natural Green Engineering Co., Ltd., a limited liability company organized under the laws of the Peoples Republic of China (“Qufu Natural Green”), and Qufu Shengwang Stevia Biology and Science Co., Ltd., a limited liability company organized under the laws of the Peoples |
|
| July 7, 2008 |
STOCK SALE AND PURCHASE AGREEMENT EX-10 3 ex1014.htm Exhibit 10.14 STOCK SALE AND PURCHASE AGREEMENT THIS STOCK SALE AND PURCHASE AGREEMENT (the “Agreement”) is made and entered as of this 30th day of June 2008 by and among Sunwin International Neutraceuticals, Inc., a Nevada corporation, (the “Company”) and Shandong Shengwang Group Co., Ltd. a limited liability company organized under the laws of the Peoples Republic of China (th |
|
| July 7, 2008 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): June 30, 2008 SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 033-10456 56-2416925 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION |
|
| May 31, 2007 |
Sunwin International Neutraceuticals, Inc 6 Youpeng Road Qufu, Shandong, China May 31, 2007 Sunwin International Neutraceuticals, Inc 6 Youpeng Road Qufu, Shandong, China May 31, 2007 United States Securities and Exchange Commission 100 F Street, N. |
|
| May 11, 2007 |
SCHNEIDER WEINBERGER & BEILLY LLP 2200 Corporate Boulevard, N.W., Suite 210 Boca Raton, Florida 33431 (561) 362-9595 (561) 362-9612 FAX ?CORRESP? May 11, 2007 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeffrey P. Riedler, Assistant Director Gregory S. Belliston, Division of Corporation Finance Re: Sunwin International Neutraceuticals, Inc. |
|
| October 11, 2006 |
Sunwin Stevia International Announces the Appointment of Jeffrey G. Reynolds as CEO Exhibit 99.1 Sunwin Stevia International Announces the Appointment of Jeffrey G. Reynolds as CEO Ft. Lauderdale, FL – October 10, 2006 (Market Wire) - Sunwin Stevia International, Corp.., a wholly owned subsidiary of Sunwin International Nutraceuticals, Inc. (OTC BB: SUWN), today announced the appointment of Jeffrey Reynolds as CEO. Mr. Reynolds will be responsible for marketing the company’s Only |
|
| October 11, 2006 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 11, 2006 SUNWIN INTERNATIONAL NUTRACEUTICALS,INC. |
|
| September 25, 2006 |
Exhibit 10.1 PROMISSORY NOTE $490,000 Date: July 6, 2006 For value received, the undersigned Sunwin International Neutraceuticals, Inc. (the "Borrower") promises to pay to the order of Wenxiu Yu (the "Lender") the sum of $490,000 without any interest by October 5, 2006. The unpaid principal shall be payable in full on or by October 6, 2006 (the "Due Date"). The Borrower reserves the right to prepa |
|
| September 25, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly report ended July 31, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number: 033-10456 SUNWIN INTERNATIONAL NEUTRACE |
|
| September 15, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NT 10-Q 1 swunnt10q91506.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 333-10456 FORM 12b-25 CUSIP NUMBER 640910204 NOTIFICATION OF LATE FILING (Check one): Form 10-KSB Form 10-F X Form 10-QSB Form N-SAR Form N-CSR For Period Ended: July 31, 2006 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Rep |
|
| August 1, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER FORM 12b-25 CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one): X Form 10-KSB Form 10-F Form 10-QSB Form N-SAR Form N-CSR For Period Ended: April 30, 2006 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-SAR |
|
| August 1, 2005 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTION, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File No. |
|
| March 17, 2005 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTION, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File No. |
|
| December 15, 2004 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTION, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File No. |
|
| September 15, 2004 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTION, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File No. |
|
| September 15, 2004 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTION, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File No. |
|
| July 30, 2004 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTION, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File No. |
|
| July 30, 2002 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTION, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File No. |
